Literature DB >> 25599919

A new look at rheumatology in China--opportunities and challenges.

Zhan-Guo Li1.   

Abstract

In the past two decades, Chinese rheumatology has developed rapidly in terms of both clinical practice and basic research. Many rheumatology departments and divisions have been established, creating positions for more residents to join rheumatology practices. Numerous studies of rheumatic diseases have been published in recent years by Chinese rheumatologists and immunologists, supported by government funding that has dramatically increased over the past few years. These studies are focused mainly on epidemiology, mechanisms, early diagnosis and interventions of rheumatic diseases. Increasing numbers of national and international scientific activities in China, including research collaborations, education programmes and conferences have greatly helped the development of rheumatology. In this APLAR series article, the major, high-impact studies and latest developments in Chinese rheumatology are reviewed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25599919     DOI: 10.1038/nrrheum.2014.218

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  51 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional study.

Authors:  Chuanhui Xu; Xiuru Wang; Rong Mu; Li Yang; Ye Zhang; Shuling Han; Xiaofeng Li; Yongfu Wang; Guochun Wang; Ping Zhu; Hongtao Jin; Lin Sun; Haiying Chen; Liufu Cui; Zhuoli Zhang; Zhenbin Li; Junfang Li; Fengxiao Zhang; Jinying Lin; Xiaomin Liu; Shaoxian Hu; Xiuyan Yang; Bei Lai; Xingfu Li; Xiaoyuan Wang; Yin Su; Zhanguo Li
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

3.  IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation.

Authors:  Min Yang; Jun Deng; Yang Liu; King-Hung Ko; Xiaohui Wang; Zhijun Jiao; Shengjun Wang; Zichun Hua; Lingyun Sun; Gopesh Srivastava; Chak-Sing Lau; Xuetao Cao; Liwei Lu
Journal:  Am J Pathol       Date:  2012-04-23       Impact factor: 4.307

4.  Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.

Authors:  Liang-Jing Lu; Chun-de Bao; Min Dai; Jia-Lin Teng; Wei Fan; Fang Du; Nan-Ping Yang; Yin-Huan Zhao; Zhi-Wei Chen; Jian-Hua Xu; Pei-Gen He; Hua-Xiang Wu; Yi Tao; Miao-Jia Zhang; Xing-Hai Han; Xing-Fu Li; Jie-Ruo Gu; Jian-Hua Li; Hao Yu
Journal:  Arthritis Rheum       Date:  2009-07-15

5.  Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody.

Authors:  Jing Zou; Ting Li; Xingfang Huang; Sheng Chen; Qiang Guo; Chunde Bao
Journal:  Ann Rheum Dis       Date:  2014-04-16       Impact factor: 19.103

6.  A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis.

Authors:  Jinpiao Lin; Rongfen Huo; Lianbo Xiao; Xianjin Zhu; Jun Xie; Songtao Sun; Yong He; Jie Zhang; Yue Sun; Zhou Zhou; Pinru Wu; Baihua Shen; Dangsheng Li; Ningli Li
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

7.  Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans.

Authors:  Lei Jiang; Jian Yin; Lingying Ye; Jian Yang; Gibran Hemani; Ai-Jun Liu; Hejian Zou; Dongyi He; Lingyun Sun; Xiaofeng Zeng; Zhanguo Li; Yi Zheng; Yiping Lin; Yi Liu; Yongfei Fang; Jianhua Xu; Yinong Li; Shengming Dai; Jianlong Guan; Lindi Jiang; Qianghua Wei; Yi Wang; Yang Li; Cibo Huang; Xiaoxia Zuo; Yu Liu; Xin Wu; Libin Zhang; Ling Zhou; Qing Zhang; Ting Li; Ling Chen; Zhen Xu; Xiaoping Yang; Feng Qian; Weilin Xie; Wei Liu; Qian Guo; Shaolan Huang; Jing Zhao; Mengmeng Li; Yanhua Jin; Jie Gao; Ying Lv; Yiwen Wang; Li Lin; Aihua Guo; Patrick Danoy; Dana Willner; Catherine Cremin; Johanna Hadler; Fengchun Zhang; Yan Zhao; Mengtao Li; Tao Yue; Xiaolei Fan; Jianping Guo; Rong Mu; Jingyi Li; Chao Wu; Ming Zeng; Jiucun Wang; Shilin Li; Li Jin; Binbin Wang; Jing Wang; Xu Ma; Liangdan Sun; Xuejun Zhang; Matthew A Brown; Peter M Visscher; Ding-Feng Su; Huji Xu
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

8.  A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.

Authors:  Yongzhe Li; Kunlin Zhang; Hua Chen; Fei Sun; Juanjuan Xu; Ziyan Wu; Ping Li; Liuyan Zhang; Yang Du; Haixia Luan; Xi Li; Lijun Wu; Hongbin Li; Huaxiang Wu; Xiangpei Li; Xiaomei Li; Xiao Zhang; Lu Gong; Lie Dai; Lingyun Sun; Xiaoxia Zuo; Jianhua Xu; Huiping Gong; Zhijun Li; Shengquan Tong; Min Wu; Xiaofeng Li; Weiguo Xiao; Guochun Wang; Ping Zhu; Min Shen; Shengyun Liu; Dongbao Zhao; Wei Liu; Yi Wang; Cibo Huang; Quan Jiang; Guijian Liu; Bin Liu; Shaoxian Hu; Wen Zhang; Zhuoli Zhang; Xin You; Mengtao Li; Weixin Hao; Cheng Zhao; Xiaomei Leng; Liqi Bi; Yongfu Wang; Fengxiao Zhang; Qun Shi; Wencheng Qi; Xuewu Zhang; Yuan Jia; Jinmei Su; Qin Li; Yong Hou; Qingjun Wu; Dong Xu; Wenjie Zheng; Miaojia Zhang; Qian Wang; Yunyun Fei; Xuan Zhang; Jing Li; Ying Jiang; Xinping Tian; Lidan Zhao; Li Wang; Bin Zhou; Yang Li; Yan Zhao; Xiaofeng Zeng; Jurg Ott; Jing Wang; Fengchun Zhang
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

9.  Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.

Authors:  Qian-Wen Lv; Wen Zhang; Qun Shi; Wen-jie Zheng; Xin Li; Hua Chen; Qing-jun Wu; Wan-lan Jiang; Hong-bin Li; Lu Gong; Wei Wei; Hui Liu; Ai-jing Liu; Hong-tao Jin; Jun-xiang Wang; Xiu-mei Liu; Zhen-bin Li; Bin Liu; Min Shen; Qian Wang; Xiang-ni Wu; Di Liang; Yu-feng Yin; Yun-yun Fei; Jing-mei Su; Li-dan Zhao; Ying Jiang; Jing Li; Fu-lin Tang; Feng-chun Zhang; Peter E Lipsky; Xuan Zhang
Journal:  Ann Rheum Dis       Date:  2014-04-14       Impact factor: 19.103

10.  Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis.

Authors:  Fanlei Hu; Rong Mu; Jiaxin Zhu; Lianjie Shi; Yingni Li; Xu Liu; Wenwei Shao; Guiye Li; Minghui Li; Yin Su; Philip L Cohen; Xiaoyan Qiu; Zhanguo Li
Journal:  Ann Rheum Dis       Date:  2013-05-03       Impact factor: 19.103

View more
  12 in total

Review 1.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

2.  Brief report on academic contributions from China on the topic of rheumatic diseases.

Authors:  Y Gao; X Liu; L Zhang; T Xia; D Zhao
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

3.  Status of rheumatology practice and professional training courses in rural areas of China-an ILAR project.

Authors:  Xue Li; Yuan Jia; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2016-10-24       Impact factor: 2.980

Review 4.  Rheumatology in Ukraine.

Authors:  Bohdana Doskaliuk; Olena Zimba; Roman Yatsyshyn; Volodymyr Kovalenko
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

5.  Inflammatory Cytokine-Neutralizing Antibody Treatment Prevented Increases in Follicular Helper T Cells and Follicular Regulatory T Cells in a Mouse Model of Arthritis.

Authors:  Xingyue Zeng; Songsong Lu; Meng Li; Mohan Zheng; Tianci Liu; Rui Kang; Lijuan Xu; Qinzhu Xu; Ying Song; Chen Liu
Journal:  J Inflamm Res       Date:  2022-07-14

6.  [Intra-articular injection of ascorbic acid/ferric chloride relieves cartilage degradation in rats with osteoarthritis].

Authors:  Zhenting Liao; Zhenquan Xing; Yufan Chen; Zhonghao Deng; Desheng Wu; Liang Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

7.  Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China.

Authors:  SiNi Li; JianHe Li; LiuBao Peng; YaMin Li; XiaoMin Wan
Journal:  Rheumatol Ther       Date:  2021-04-24

8.  The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.

Authors:  Yuan An; Tian Liu; Dongyi He; Lijun Wu; Juan Li; Yi Liu; Liqi Bi; Bin Zhou; Changsong Lin; Lan He; Xiangyuan Liu; Xiaofeng Li; Niansheng Yang; Zhuoli Zhang; Hui Song; Wei Wei; Jing Liu; Yu Bi; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2016-10-05       Impact factor: 2.980

Review 9.  Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.

Authors:  Qin Wang; Xianyan Qin; Jiyu Fang; Xun Sun
Journal:  Acta Pharm Sin B       Date:  2021-03-12       Impact factor: 11.413

10.  Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-κB in a Rat Model of Rheumatoid Arthritis.

Authors:  Zeng-Bing Xia; Yong-Jian Yuan; Qiang-Hua Zhang; Heng Li; Ji-Lin Dai; Ji-Kang Min
Journal:  Med Sci Monit       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.